Barriers to early clinical trial access for adolescents and young adults still exist

(European Society for Medical Oncology) Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and paediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news